United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $863,622,062.25
Most recent insider trade:
  • Aug. 7, 2025
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Oct. 3, 2013EVP6,000$84.38Sell$506,280.00
Oct. 3, 2013Director1,500$83.15Sell$124,725.00
Sept. 26, 2013CEO3,833$78.41Sell$300,545.53
Sept. 20, 2013COO10,000$77.86Sell$778,600.00
Sept. 19, 2013CEO3,833$78.12Sell$299,433.96
Sept. 19, 2013CFO4,500$78.67Sell$354,015.00
Sept. 19, 2013EVP6,000$78.02Sell$468,120.00
Sept. 12, 2013CEO3,833$76.98Sell$295,064.34
Sept. 6, 2013COO10,000$73.67Sell$736,700.00
Sept. 5, 2013CFO4,500$74.17Sell$333,765.00
Sept. 5, 2013CEO3,833$73.63Sell$282,223.79
Sept. 5, 2013EVP6,000$73.29Sell$439,740.00
Sept. 5, 2013Director1,500$73.11Sell$109,665.00
Aug. 29, 2013CEO3,833$72.76Sell$278,889.08
Aug. 22, 2013CEO3,833$72.06Sell$276,205.98
Aug. 16, 2013COO10,000$71.21Sell$712,100.00
Aug. 15, 2013EVP6,000$71.34Sell$428,040.00
Aug. 15, 2013CFO4,500$71.14Sell$320,130.00
Aug. 15, 2013CEO3,833$71.58Sell$274,366.14
Aug. 8, 2013CEO3,833$73.11Sell$280,230.63
Aug. 2, 2013COO10,000$76.69Sell$766,900.00
Aug. 1, 2013Director3,000$75.94Sell$227,820.00
Aug. 1, 2013EVP6,000$75.91Sell$455,460.00
Aug. 1, 2013CFO4,500$75.87Sell$341,415.00
Aug. 1, 2013CEO3,833$75.97Sell$291,193.01
July 31, 2013Director7,500$74.93Sell$561,975.00
July 25, 2013CEO3,833$71.45Sell$273,867.85
July 19, 2013COO10,000$70.00Sell$700,000.00
July 18, 2013CFO9,000$69.85Sell$628,650.00
July 18, 2013CEO3,833$68.96Sell$264,323.68
July 18, 2013EVP6,000$69.15Sell$414,900.00
July 11, 2013CEO3,837$67.94Sell$260,685.78
July 5, 2013COO10,000$67.21Sell$672,100.00
July 5, 2013CEO3,863$67.28Sell$259,902.64
July 5, 2013Director1,500$66.33Sell$99,495.00
July 5, 2013EVP6,000$67.04Sell$402,240.00
June 21, 2013COO10,000$63.34Sell$633,400.00
June 20, 2013EVP6,000$63.29Sell$379,740.00
June 20, 2013CFO4,500$63.22Sell$284,490.00
June 7, 2013COO10,000$67.00Sell$670,000.00
June 6, 2013Director3,000$63.77Sell$191,310.00
June 6, 2013EVP6,000$63.84Sell$383,040.00
June 6, 2013CFO4,500$64.84Sell$291,780.00
May 17, 2013COO10,000$69.17Sell$691,700.00
May 16, 2013EVP6,000$68.05Sell$408,300.00
May 16, 2013CFO4,500$68.48Sell$308,160.00
May 2, 2013EVP6,000$67.15Sell$402,900.00
May 2, 2013Director3,000$66.75Sell$200,250.00
April 11, 2013Director9,000$61.35Sell$552,150.00
Jan. 17, 2013EVP5,749$52.20Sell$300,097.80
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Paul A. Mahon, Ray Kurzweil, Tommy G. Thompson, DWEK RAYMOND, MAHON PAUL A, R Paul Gray, Louis Sullivan, and Judy D. Olian

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Aug. 7, 2025.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.